ATLAS fair value
DKK 736.28
Below fair value · 35% discount
Coloplast stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · Nasdaq Copenhagen · Denmark
Prices as of Oct 27, 2026 · DKK
DKK 736.28
Below fair value · 35% discount
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Coloplast's fair value at about DKK 736.28 per share (reasonable range: DKK 559.73 to DKK 1,306). At DKK 477.50, the stock trades 35% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Coloplast a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between DKK 457.03 and DKK 501.68; in 9 out of 10, between DKK 420.78 and DKK 544.89. Estimated annual volatility is 28%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Coloplast sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks COLO-B.CO has traded between DKK 369.70 and DKK 631.40. Today it is 24.4% below that high and 29% above its low.
On the business: net margin is 9.7%; it trades at 38.4 times earnings.
Its beta is 0.56: it tends to move less than the market.
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Want to see everything about Coloplast?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About DKK 736.28 per share according to ATLAS (reasonable range: DKK 559.73 to DKK 1,306). With the stock at DKK 477.50, it is 35% below it.
52%: close to a coin flip. In half of the simulated outcomes, COLO-B.CO ends the month between DKK 457.03 and DKK 501.68.
Coloplast's market capitalization is DKK 106B. Its price-to-earnings (P/E) ratio is 38.4: you pay DKK 38.4 for each DKK 1.00 of yearly earnings.
Yes. COLO-B.CO's current dividend yield is 4.83% at today's price (DKK 477.50).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy